LINGEGOWDA SELANERE MANGALA to Protein Kinase Inhibitors
This is a "connection" page, showing publications LINGEGOWDA SELANERE MANGALA has written about Protein Kinase Inhibitors.
Connection Strength
0.108
-
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. Int J Mol Sci. 2023 Feb 15; 24(4).
Score: 0.071
-
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. J Clin Invest. 2007 Dec; 117(12):4044-54.
Score: 0.025
-
Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies. J Natl Cancer Inst. 2017 07 01; 109(7).
Score: 0.012